Champions Oncology Inc
CSBR6.310USD
+0.150+2.44%
Market hours （ET）Quotes delayed by 15 min
86.93MMarket Cap
13.53P/E TTM
More Details of Champions Oncology Inc Company
Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
Company Info
Ticker SymbolCSBR
Company nameChampions Oncology Inc
IPO dateNov 30, 1988
CEODr. Ronnie Morris, M.D.
Number of employees213
Security typeOrdinary Share
Fiscal year-endNov 30
AddressOne University Plaza,
CityHACKENSACK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code07601
Phone12018088400
Websitehttps://championsoncology.com
Ticker SymbolCSBR
IPO dateNov 30, 1988
CEODr. Ronnie Morris, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Chairman of the Board
Independent Chairman of the Board
962.13K
+12.27%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
30.00K
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Chairman of the Board
Independent Chairman of the Board
962.13K
+12.27%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Lead Independent Director
Lead Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
30.00K
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q3
No Data
By RegionUSD
Name
Revenue
Proportion
United States
17.04M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, May 18
Updated: Sun, May 18
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Battery Management Corp
17.58%
New Enterprise Associates (NEA)
12.44%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.41%
Morris (Ronnie)
6.23%
Other
50.36%
Shareholders
Shareholders
Proportion
Battery Management Corp
17.58%
New Enterprise Associates (NEA)
12.44%
Ackerman (Joel)
6.98%
West Elk Capital, LLC
6.41%
Morris (Ronnie)
6.23%
Other
50.36%
Shareholder Types
Shareholders
Proportion
Individual Investor
25.95%
Investment Advisor
22.93%
Venture Capital
12.44%
Hedge Fund
8.24%
Investment Advisor/Hedge Fund
5.15%
Research Firm
0.71%
Pension Fund
0.08%
Other
24.51%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
69
10.40M
75.49%
-158.72K
2025Q1
71
10.39M
75.16%
-168.96K
2024Q4
61
10.19M
73.72%
-652.40K
2024Q3
60
10.19M
74.57%
-703.73K
2024Q2
64
9.36M
69.10%
-280.60K
2024Q1
64
9.22M
68.06%
-286.03K
2023Q4
62
9.19M
67.80%
-359.18K
2023Q3
68
10.27M
76.17%
-73.57K
2023Q2
73
10.30M
76.08%
-426.58K
2023Q1
98
10.36M
76.50%
-511.14K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Battery Management Corp
2.42M
17.51%
--
--
Mar 31, 2025
New Enterprise Associates (NEA)
1.71M
12.39%
--
--
Mar 31, 2025
Ackerman (Joel)
962.13K
6.96%
+105.14K
+12.27%
Oct 31, 2024
West Elk Capital, LLC
882.58K
6.38%
-210.81K
-19.28%
Sep 30, 2024
Morris (Ronnie)
858.88K
6.21%
--
--
Aug 26, 2024
Sidransky (David)
767.04K
5.55%
--
--
Aug 26, 2024
Pessin (Norman H)
742.16K
5.37%
--
--
Aug 26, 2024
Tocqueville Asset Management LP
399.88K
2.89%
-209.03K
-34.33%
Mar 31, 2025
The Vanguard Group, Inc.
307.87K
2.23%
+872.00
+0.28%
Mar 31, 2025
Mendelson (Daniel Newman)
198.63K
1.44%
+20.00
+0.01%
Aug 26, 2024
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
